Levels of phosphorylated p65, the indicator of NFκB activation, was significantly decreased in P1 glioma xenografts with AAV-sh-Gαi2 injection (Figure 8H), whereas caspase-3 and PARP cleavages were augmented (Figure 8I). Here, CASP3 is linked to central nervous system cancer.